Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

for the treatment of adults and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Cytopoint (lokivetmab) injections for dogs with atopic dermatitis are injected under the skin (subcutaneously) every four to ...

The single-injection 2 mL prefilled syringe and autoinjector ... its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating the efficacy of the ointment’s 2% ...

Dermatitis refers to skin inflammation. Types include atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, and dishydrotic dermatitis. Symptoms may include dry skin, itchiness ...

14 Atopic dermatitis is a common ... nemolizumab (marketed as Nemluvio ®) as a pre-filled pen for subcutaneous injection for the treatment of adults with prurigo nodularis in August 2024.

Approximately 120 patients will be randomly assigned on a 1:1:1 ratio to receive subcutaneous injections of barzolvolimab ... esophagitis (EOE) and atopic dermatitis (AD), with additional ...